Results 41 to 50 of about 59,669 (311)
Heterogeneity in susceptibility to hydroxychloroquine of SARS-CoV-2 isolates
Frontiers in Bioscience-Landmark, 2021 Background: Despite the fact that the clinical efficacy of hydroxychloroquine is still controversial, it has been demonstrated in vitro to control SARS-CoV-2 multiplication on Vero E6 cells.
Celine Boschi +10 more
doaj +1 more source
A Multi-Opinion Based Method for Quantifying Polarization on Social Networks [PDF]
arXiv, 2022 Social media platforms have emerged as a hub for political and social interactions, and analyzing the polarization of opinions has been gaining attention. In this study, we have proposed a measure to quantify polarization on social networks. The proposed metric, unlike state-of-the-art methods, does not assume a two-opinion case and applies to multiple
arxiv
Hydroxychloroquine-induced erythroderma
Indian Journal of Pharmacology, 2017 Erythroderma is characterized by diffuse erythema and scaling of the skin involving more than 90% of the total body skin surface area. Drug-induced erythroderma has rarely been reported with hydroxychloroquine. We report a case of a 50-year-old female patient, with systemic lupus erythematosus, who developed itchy lesions all over the body 1 month ...
Maria Kuruvilla +4 more
openaire +2 more sources
Case Reports in Infectious Diseases, 2020 Hydroxychloroquine has gained popularity as a potential preventative and treatment of COVID-19 pneumonia due to its in vitro activity against the virus.
Awan K. Rahman +2 more
doaj +1 more source
Scientific Reports, 2021 Hydroxychloroquine has recently received attention as a treatment for COVID-19. However, it may prolong the QTc interval. Furthermore, when hydroxychloroquine is administered concomitantly with other drugs, it can exacerbate the risk of QT prolongation ...
Byung Jin Choi +8 more
doaj +1 more source
CPT: Pharmacometrics &Systems Pharmacology, Volume 12, Issue 1, Page 13-26, January 2023., 2023 Abstract The pharmacokinetics (PKs) and safety of medications in particular groups can be predicted using the physiologically‐based pharmacokinetic (PBPK) model. Using the PBPK model may enable safe pediatric clinical trials and speed up the process of new drug research and development, especially for children, a population in which it is relatively ...
Xu Zhou +5 more
wiley +1 more source
Understanding Public Opinion on Using Hydroxychloroquine for COVID-19 Treatment via Social Media [PDF]
arXiv, 2022 Hydroxychloroquine (HCQ) is used to prevent or treat malaria caused by mosquito bites. Recently, the drug has been suggested to treat COVID-19, but that has not been supported by scientific evidence. The information regarding the drug efficacy has flooded social networks, posting potential threats to the community by perverting their perceptions of the
arxiv
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016 BackgroundCardiovascular disease (CVD) is the leading cause of death in rheumatoid arthritis (RA) patients. This study is the first to report the association of hydroxychloroquine (an antirheumatic medication that has been associated with decreased risk ...
Tarun S. Sharma +6 more
doaj +1 more source
BMJ Open, 2021 Objective To describe the pattern of hydroxychloroquine use and examine the association between hydroxychloroquine use and clinical outcomes arising from changes in the US Food and Drug Administration (FDA)’s recommendation during the coronavirus disease
+20 more
doaj +1 more source
Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID‐19 vaccination
, 2022 The Kaohsiung Journal of Medical Sciences, Volume 38, Issue 12, Page 1230-1231, December 2022.
Huei‐Jing Wang +2 more
wiley +1 more source